21,226 Shares in Genpact Limited (G) Acquired by Sciencast Management LP

Sciencast Management LP purchased a new position in shares of Genpact Limited (NYSE:G) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 21,226 shares of the business services provider’s stock, valued at approximately $731,000.

Several other institutional investors have also modified their holdings of G. Ameriprise Financial Inc. lifted its stake in shares of Genpact by 70.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 51,396 shares of the business services provider’s stock valued at $1,478,000 after buying an additional 21,200 shares in the last quarter. Bank of Montreal Can lifted its stake in shares of Genpact by 213.4% during the 4th quarter. Bank of Montreal Can now owns 342,157 shares of the business services provider’s stock valued at $10,860,000 after buying an additional 232,992 shares in the last quarter. California Public Employees Retirement System lifted its stake in shares of Genpact by 5.7% during the 4th quarter. California Public Employees Retirement System now owns 480,516 shares of the business services provider’s stock valued at $15,252,000 after buying an additional 25,933 shares in the last quarter. BNP Paribas Arbitrage SA lifted its stake in shares of Genpact by 454.5% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 25,319 shares of the business services provider’s stock valued at $728,000 after buying an additional 20,753 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Genpact by 13.3% during the 4th quarter. Victory Capital Management Inc. now owns 97,943 shares of the business services provider’s stock valued at $3,109,000 after buying an additional 11,505 shares in the last quarter. Institutional investors and hedge funds own 91.01% of the company’s stock.

A number of research analysts recently weighed in on G shares. Cantor Fitzgerald restated a “buy” rating and set a $36.00 target price on shares of Genpact in a research note on Tuesday, February 13th. BMO Capital Markets lifted their target price on shares of Genpact to $35.00 and gave the company a “market perform” rating in a research note on Tuesday, February 13th. Zacks Investment Research downgraded shares of Genpact from a “hold” rating to a “sell” rating in a report on Thursday, February 15th. JPMorgan Chase reduced their price target on shares of Genpact from $38.00 to $37.00 and set a “neutral” rating on the stock in a report on Wednesday, February 14th. Finally, Citigroup reduced their price target on shares of Genpact from $39.00 to $37.50 and set a “buy” rating on the stock in a report on Tuesday, February 13th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company’s stock. Genpact has a consensus rating of “Buy” and a consensus target price of $34.65.

In other news, Director James C. Madden sold 4,270 shares of the business’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $30.92, for a total value of $132,028.40. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $33.95, for a total transaction of $770,325.50. The disclosure for this sale can be found here. Insiders own 1.41% of the company’s stock.

Genpact stock opened at $31.34 on Friday. Genpact Limited has a twelve month low of $23.34 and a twelve month high of $34.79. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.71 and a current ratio of 1.71. The stock has a market capitalization of $6,231.96, a PE ratio of 21.03, a price-to-earnings-growth ratio of 2.07 and a beta of 0.60.

Genpact (NYSE:G) last posted its earnings results on Monday, February 12th. The business services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.02. Genpact had a net margin of 9.61% and a return on equity of 22.75%. The firm had revenue of $734.41 million for the quarter, compared to the consensus estimate of $723.55 million. During the same period in the previous year, the firm posted $0.43 EPS. The business’s quarterly revenue was up 7.7% on a year-over-year basis. equities analysts forecast that Genpact Limited will post 1.55 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 21st. Stockholders of record on Friday, March 9th were issued a $0.075 dividend. The ex-dividend date was Thursday, March 8th. This is an increase from Genpact’s previous quarterly dividend of $0.06. This represents a $0.30 dividend on an annualized basis and a dividend yield of 0.96%. Genpact’s payout ratio is 20.13%.

COPYRIGHT VIOLATION NOTICE: “21,226 Shares in Genpact Limited (G) Acquired by Sciencast Management LP” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/07/sciencast-management-lp-takes-731000-position-in-genpact-limited-g.html.

Genpact Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply